Exercise Training Study of Patients With Claudicatio Intermittens
Randomized Clinical Trial on the Effects of Home-based Five Plus Exercise Training
1 other identifier
interventional
100
2 countries
14
Brief Summary
The aim of the study is to evaluate whether walking capacity in patients with intermittent claudication is improved more by home-based 5+ exercise training than by current recommendations of daily walking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Typical duration for not_applicable
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 3, 2024
CompletedFirst Posted
Study publicly available on registry
June 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJune 6, 2025
June 1, 2025
2 years
June 3, 2024
June 5, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
walking distance
Measured on a tread mill before and after the training period
12 weeks
Quality of life
Measured with a questionnaire (VASCUQOL-6) before and after the training period
12 weeks
Study Arms (2)
Five plus training
ACTIVE COMPARATORDuring "five plus training" the participants are standing in front of a wall, which is used for support of the balance. The body is lifted with the calf musculature to the maximal height that the subject can achieve. This is repeated until pain is felt in the calf musculature. Following the initiation of pain the subject performs five extra repetitions. The five extra calf raises are included to secure induction of ischemia followed by reperfusion to secure maximal training effect.
walking
ACTIVE COMPARATORWalking at least 30 minutes three times per week.
Interventions
The patients are randomized to either walking 30 minutes 3 times a week or lifting the body to a tip toe position three times a day until pain in the claves and then add another five liftings before ending the session
Eligibility Criteria
You may qualify if:
- Pain in the calves after 300 m, or less measured on a treadmill
- Stable symptoms last 6 months or more
- The pain must be gone within 5 minutes after the patients stop walking
- Ankle-Brachial index at 0.7 or lower at rest
- Using statins and antiplatelet drugs since at least 3 months
- age\> 18 years
- Signed consent
You may not qualify if:
- pain in the hips or elsewhere outside the calves while walking
- Remaining pain more than 5 minutes after stopped walking.
- Impossible to compress the arteries while measruing ABI or ABI lower than 0.4
- Use of statins and antiplatelet drugs less than 3 months
- symptoms less than 6 months
- Diabetes measured with HbA1c being over 48 mmol/mol (6%)
- Revascularisation the last 6 months
- Pain in the calves after longer than 300 m measured on a treadmill
- Reduced mobility in the ankles
- Reduced physical ability to perform a test on a treadmill.
- Age less than 18 years
- General conditions that impairs the ability to take part in a training study including Obesity, KOLS, heart disease, arthrosis, inflammatory joint diseases .
- No Signed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- Sykehuset i Vestfold HFcollaborator
- Oslo University Hospitalcollaborator
- Haukeland University Hospitalcollaborator
- Sorlandet Hospital HFcollaborator
- St. Olavs Hospitalcollaborator
- Sykehuset Ostfoldcollaborator
- Helse Stavanger HFcollaborator
- Sykehuset Innlandet HFcollaborator
- Drammen sykehuscollaborator
- Alesund Hospitalcollaborator
- Sahlgrenska University Hospitalcollaborator
- Karolinska Institutetcollaborator
- University Hospital, Linkoepingcollaborator
Study Sites (14)
Ålesund Sykehus
Ålesund, Norway
Haukeland University Hospital
Bergen, Norway
Vestre Viken, Drammen sykehus
Drammen, Norway
Sykehuset Østfold Kalnes
Grålum, Norway
Sykehuset Innlandet HF
Hamar, Norway
Sørlandet Sykehus HF Kristiansand
Kristiansand, Norway
Ahus University Hospital
Oslo, Norway
Oslo university Hospital
Oslo, Norway
Stavanger University Hospital
Stavanger, Norway
St Olavs University Hospital
Trondheim, Norway
Sykehuset i Vestfold HF
Tønsberg, Norway
Sahlgrenska University Hospital
Gothenburg, Sweden
Linköping University Hiospital
Linköping, Sweden
Karolinska Institute
Stockholm, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joakim Nordanstig, Professor
Sahlgrenska University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The care provider instructs about the training version. Other people will evaluate the participants before and after the training period
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2024
First Posted
June 7, 2024
Study Start
January 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
June 6, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
According to the ethical permission no individual data can be shared or identified. The participant can be fully informed if that is requested